Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5821596 | Antiviral Research | 2016 | 4 Pages |
Abstract
The recently developed human norovirus (HuNoV) B cell culture and mouse models hold promise for drug discovery and development but their suitability for antiviral studies has not been assessed. We demonstrate the inhibitory effect of the nucleoside analogue 2â²-C-methylcytidine (2CMC) on HuNoV replication in the human B cell BJAB cell line and in Balb/c Rag/gamma chain-deficient (Rag-γcâ/â) mice. These data suggest the applicability of both models for future study and development of antiviral drugs for the treatment of HuNoV infections.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Abimbola O. Kolawole, Joana Rocha-Pereira, Michael D. Elftman, Johan Neyts, Christiane E. Wobus,